The program looks to support “faster, more coordinated approaches to emerging regulatory challenges and decisions,” the United Kingdom’s MHRA said. More: FDA, UK drug regulator deepen transatlantic ties with new liaison program Source: fierce
read moreAs it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. The company has hired Ester Banque to become its CCO and has elevated president Stephen Hoge, M.D., to
read moreStealth BioTherapeutics is looking to put its tumultuous path behind it with a new name. More: Stealth BioTherapeutics removes cloak to become Mighty Source: fierce
read moreRecipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for customers. More: Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
read moreDeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases using natural language. More: DeepIntent gives Helix an AI twist to help marketers query data Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals